| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | $10.2B | $9.9B | $10.1B | $10.3B | $9.5B | $7.8B | $7.6B | $7.6B |
| Gross Profit | $1.9B | $2.0B | $2.0B | $2.2B | $1.9B | $0.5B | $0.5B | $0.5B |
| R&D Expense | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| SG&A Expense | $1.0B | $1.0B | $0.9B | $0.9B | $0.9B | $0.8B | $0.7B | $0.8B |
| Operating Income | $0.7B | $1.1B | $1.1B | $1.3B | $1.1B | $1.1B | $1.2B | $1.2B |
| Net Income | $0.5B | $0.8B | $0.8B | $1.0B | $0.9B | $0.2B | $0.3B | $0.3B |
| EPS (Basic) | $0.87 | $1.47 | $1.45 | $1.84 | $1.68 | $0.43 | $0.48 | $0.49 |
| EPS (Diluted) | $0.87 | $1.47 | $1.45 | $1.82 | $1.66 | $0.43 | $0.47 | $0.48 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $13.4B | $13.4B | $13.4B | $13.3B | $12.7B | $9.9B | $8.1B | $8.1B |
| Current Assets | $3.4B | $3.2B | $3.3B | $3.6B | $2.9B | $3.6B | $2.4B | $2.1B |
| Cash & Equivalents | $0.7B | $0.7B | $0.7B | $1.0B | $0.6B | $1.7B | $0.7B | $0.5B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $1.4B | $1.4B | $2.3B | $1.5B | $1.4B | $1.5B | $1.1B | $1.1B |
| Stockholders' Equity | $7.9B | $8.0B | $7.7B | $7.5B | $7.0B | $6.4B | $5.9B | $5.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.8B | $1.3B | $1.0B | $1.1B | $1.0B | $1.1B | $0.9B | $1.2B |
| Investing Cash Flow | $-0.3B | $-0.2B | $-0.7B | $-0.3B | $-3.6B | $-0.7B | $0.2B | $-1.2B |
| Capital Expenditures | $0.3B | $0.3B | $0.3B | $0.3B | $0.2B | $0.4B | $0.3B | $0.4B |
| Financing Cash Flow | $-0.6B | $-1.0B | $-0.6B | $-0.5B | $1.5B | $0.6B | $-0.9B | $0.0B |